Fig. 14
From: Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme
TIDE and immune checkpoint analysis. (A) Boxplot showing the level differences of immune checkpoints between high-risk and low-risk groups. (B) Differences in T cell dysfunction, T cell exclusion, and TIDE score between high-risk and low-risk groups. (C)Sankey diagram illustrating the predicted response to immunotherapy based on TIDE analysis